Ever Supreme Bio Technology Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 116.88 million compared to TWD 123.49 million a year ago. Net income was TWD 115.66 million compared to net loss of TWD 9.26 million a year ago.

Basic earnings per share from continuing operations was TWD 1.5459 compared to basic loss per share from continuing operations of TWD 0.124 a year ago. Diluted earnings per share from continuing operations was TWD 1.5369 compared to diluted loss per share from continuing operations of TWD 0.124 a year ago.